Results 71 to 80 of about 110,071 (192)

A Luciferase-Based Approach for Functional Screening of 5′ and 3′ Untranslated Regions of the mRNA Component for mRNA Vaccines

open access: yes
Background/Objectives: The recent COVID-19 pandemic caused by SARS-CoV-2 infection has highlighted the need for protocols for rapid development of efficient screening methods to search for the optimal mRNA vaccine structures against mutable viral agents.
Nikita Shepelev   +15 more
core   +1 more source

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond

open access: yes, 2021
To successfully protect against pathogen infection, a vaccine must elicit efficient adaptive immunity, including B and T cell responses. While B cell responses are key, as they can mediate antibody-dependent protection, T cells can modulate B cell ...
Emily Bettini, Michela Locci
core   +1 more source

RNA vaccines: The dawn of a new age for tuberculosis?

open access: yesHuman Vaccines & Immunotherapeutics
Since 2019, there has been a growing focus on mRNA vaccines for infectious disease prevention, particularly following the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Junli Li   +6 more
doaj   +1 more source

Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review

open access: yes, 2023
Wubetu Yihunie,1 Getinet Nibret,1 Yibeltal Aschale2 1Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia; 2Department of Medical Laboratory Science, College of Health Sciences, Debre Markos University ...
Yihunie W, Nibret G, Aschale Y
core  

Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants

open access: yes, 2022
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions of individuals and is the cause of the current global coronavirus disease 2019 (COVID-19) pandemic.
Zihui Fang   +21 more
core   +1 more source

Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection

open access: yes, 2021
The aim of this study was to assess adverse reactions to COVID-19 vaccines, comparing the BNT162b2 or the mRNA-1273 COVID-19 vaccines and the presence and seriousness of a previous COVID-19 infection.
Antònia Agustí   +10 more
core   +1 more source

mRNA Vaccine Technology Beyond COVID-19

open access: yes
Background/Objectives: Since their approval in early 2020, mRNA vaccines have gained significant attention since the COVID-19 pandemic as a potential therapeutic approach to tackle several infectious diseases.
Florence Akinyi   +3 more
core   +1 more source

mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends

open access: yesBiomarker Research
Malignant tumors remain a primary cause of human mortality. Among the various treatment modalities for neoplasms, tumor vaccines have consistently shown efficacy and promising potential.
Yu Gao   +4 more
doaj   +1 more source

Malaria Vaccines: From the Past towards the mRNA Vaccine Era

open access: yes, 2023
Plasmodium spp. is the etiological agent of malaria, a life-threatening parasitic disease transmitted by infected mosquitoes. Malaria remains a major global health challenge, particularly in endemic regions.
Maria E. Tsoumani   +2 more
core   +1 more source

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines [PDF]

open access: yes
Current clinical guidelines support the concomitant administration of seasonal influenza vaccines and COVID-19 mRNA boosters vaccine. Whether dual vaccination may impact vaccine immunogenicity due to an interference between influenza or SARS-CoV-2 ...
María Del Mar Muñoz-García (17812548)   +21 more
core   +2 more sources

Home - About - Disclaimer - Privacy